NT-proBNP Fast Test Kit
- UID
- IMP/IVD/2022/000153_580cb484c1bde95053451e8e8c06b28c_a20a4c19a556489aa41db51ef9e86fb5
- Device class
- Class C
- Brand name
- Immunofluorescence Assay
- License holder
- Cipla Limited
- Approving authority
- CDSCO
- Product information
- NT-proBNP Fast Test Kit (Immunofluorescence Assay) is intended for in vitro quantitative determination of N-terminal B-type natriuretic peptide precursor (Immunofluorescence Assay) in human serum, plasma or whole blood samples. This test is used as an aid in the clinical diagnosis, prognosis and evaluation of Heart Failure (Immunofluorescence Assay)
NT-proBNP Fast Test Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000153_580cb484c1bde95053451e8e8c06b28c_a20a4c19a556489aa41db51ef9e86fb5. This device is marketed under the brand name Immunofluorescence Assay. The license holder is Cipla Limited, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.